Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Osteosarcoma × Clinical Protocols × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 4 Recurrence 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Pneumonia 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Neoplasms, Plasma Cell 1 Neoadjuvant Therapy in Rectal Cancer, Radiotherapy, FOLFOX 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Lymphoma, T-Cell 1 Lymphoma, Mantle-Cell 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell 1 Lung Neoplasms 1 Lung Diseases, Interstitial 1 Locally Advanced Breast Cancer 1 Hepatitis 1 Fibrosis 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Carcinoma 1 Breast Neoplasms 1

Interventions

Ifosfamide 20 Methotrexate 19 Cyclophosphamide 18 Doxorubicin 16 Cisplatin 13 Gemcitabine 10 Filgrastim 10 Etoposide 10 Leucovorin 8 fludarabine 7 apatinib 7 Radiotherapy 6 Nivolumab 6 Neoadjuvant Therapy 6 Drug Therapy 6 Zoledronic Acid 5 Vincristine 5 Temozolomide 5 Mesna 5 Irinotecan 5 Granulocyte Colony-Stimulating Factor 5 Docetaxel 5 Carboplatin 5 regorafenib 4 pegfilgrastim 4 glucarpidase 4 cabozantinib 4 Topotecan 4 Surveys and Questionnaires 4 Sunitinib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04132895 2024-08-02

ICONIC

University College, London

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡